Secondary Logo

Journal Logo

April 2018 - Volume 41 - Issue 4
pp: 321-423


A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction

Blum Murphy, Mariela A.; Qiao, Wei; Mewada, Nishith; More

American Journal of Clinical Oncology. 41(4):321-325, April 2018.

Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases

Shilkrut, Mark; Sapir, Eli; Hanasoge, Sheela; More

American Journal of Clinical Oncology. 41(4):326-331, April 2018.

Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial

Pokuri, Venkata K.; Tomaszewski, Garin M.; Ait-Oudhia, Sihem; More

American Journal of Clinical Oncology. 41(4):332-338, April 2018.


Soft Tissue




EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non–Small Cell Lung Cancer Patients

Choi, Yong Won; Jeon, So Yeon; Jeong, Geum Sook; More

American Journal of Clinical Oncology. 41(4):385-390, April 2018.

Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non–Small Cell Lung Cancer Receiving Sequential Treatment

Maquilan, Genevieve; Grover, Surbhi; Xanthopoulos, Eric; More

American Journal of Clinical Oncology. 41(4):391-395, April 2018.

Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123

Small, William Jr; James, Jennifer L.; Moore, Timothy D.; More

American Journal of Clinical Oncology. 41(4):396-401, April 2018.